Evidence map›Paper›PMID 31988968›Full record

ArticleEye and vision (London, England)2020

Design and baseline data of a population-based metabonomics study of eye diseases in eastern China: the Yueqing Ocular Diseases Investigation.

Yuxuan Deng, Yuanbo Liang, Sigeng Lin, Liang Wen, Jin Li, Yue Zhou, Meixiao Shen, Jingwei Zheng, Kemi Feng, Yanting Sun and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Eye and vision (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Yuxuan Deng1Clinical and Epidemiological Research Center, Eye Hospital of Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Yuanbo Liang1Clinical and Epidemiological Research Center, Eye Hospital of Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Sigeng Lin1Clinical and Epidemiological Research Center, Eye Hospital of Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Liang WenEye Hospital of Fushun City, 1 Hupo Road, Fushun, 113006 Liaoning China.
Jin Li2School of Ophthalmology and Optometry, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Yue Zhou2School of Ophthalmology and Optometry, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Meixiao Shen2School of Ophthalmology and Optometry, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Jingwei Zheng1Clinical and Epidemiological Research Center, Eye Hospital of Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Kemi Feng1Clinical and Epidemiological Research Center, Eye Hospital of Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Yanting Sun6Qilu Hospital of Shandong University (Qingdao), 758 Hefei Road, Qingdao, 266035 Shandong China.
Kwapong Willaim Robert2School of Ophthalmology and Optometry, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Jia Qu2School of Ophthalmology and Optometry, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Fan Lu2School of Ophthalmology and Optometry, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027 Zhejiang China.
Wenzhou Medical University · CNAffiliated Eye Hospital of Wenzhou Medical College · CNQilu Hospital of Shandong University · CNWuhu No 1 People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChina is undergoing a massive transition toward an urban and industrial economy. These changes will restructure the demographics and economy which will eventually influence the future patterns of disease. The risk factors of vision-impairing eye diseases remain ambiguous and poorly understood. Metabolomics is an ideal tool to understand and shed light on the ocular disease mechanisms for earlier treatment. This article aims to describe the design, methodology and baseline data of the Yueqing Ocular Diseases Investigation (YODI), a developed county population-based study to determine the prevalence and primary causes of visual impairment; also with metabonomics analysis we aimed to identify, predict and suggest some preventive biomarkers that cause blindness.

methodsA population-based, cross-sectional study. Randomized clustering sampling was used to identify adults aged 50 years and older in Xiangyang Town, Yueqing county-level City. The interviews covered demographic, behavioral, ocular risk factors and mental health state. The ocular examination included visual acuity, autorefraction, intraocular pressure, anterior and posterior segment examinations, fundus photography, retinal tomography and angiography, and visual field testing. Anthropometric measurements included height and weight, waist and hip circumference, blood pressure, pulse rate, electrocardiogram, and abdominal ultrasound scan. A venous blood sample was collected for laboratory tests and metabonomics studies.

resultsOf the 5319 individuals recruited for the YODI, 4769 (89.7%) subjects were enrolled for analyses. The median age was 62.0 years, and 45.6% were male. The educational level of illiteracy or semi-illiteracy, primary, middle and high school or above was 29.8%, 45.5%, 20.1%, and 3.3%, respectively. Majority of the participants were female, younger, and less educated when compared with nonparticipants. The average body mass index and waist-hip ratios were 24.4 ± 3.4 kg/m

conclusionsThe YODI provides population-based data with a high response rate (89.7%) on the prevalence and primary causes of major vision-impairing eye diseases in developed county areas in eastern China. Metabonomics analysis from YODI will provide further association of metabolic characteristics with the visual impairment eye diseases. The risk prediction model could be created and has the potential to be generalized to developed eastern areas in China for prevention.

Indexed as

BaselineMetabonomicsOphthalmic epidemiologyPopulationScreeningVisual impairment

Identifiers

PMID31988968
PMCPMC6969972
OpenAlexW2999510371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.